James Mackaness - Jan 2, 2025 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ James Mackaness
Stock symbol
SLNO
Transactions as of
Jan 2, 2025
Transactions value $
-$360,460
Form type
4
Date filed
1/6/2025, 09:56 PM
Previous filing
Oct 3, 2024
Next filing
Jan 23, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Sale -$171K -3.76K -3.16% $45.37 115K Jan 2, 2025 Direct F1, F2, F3
transaction SLNO Common Stock Sale -$14.7K -321 -0.28% $45.92 115K Jan 2, 2025 Direct F1, F3, F4
transaction SLNO Common Stock Sale -$175K -3.79K -3.29% $46.18 111K Jan 3, 2025 Direct F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
F2 This transaction was executed in multiple trades at prices ranging from $44.80 to $45.79. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F4 This transaction was executed in multiple trades at prices ranging from $45.83 to $46.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $45.715 to $46.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.